(in millions of euros) | 31/12/2022 | 31/12/2021 | Variation |
---|---|---|---|
Marketable securities | Marketable securities 31/12/2022 18,447 |
Marketable securities 31/12/202110,605 |
Marketable securities Variation7,842 |
Cash and cash equivalents | Cash and cash equivalents 31/12/2022 6,918 (1) |
Cash and cash equivalents 31/12/20218,433 (1) |
Cash and cash equivalents Variation(1,515) |
Sub-total in balance sheet assets | Sub-total in balance sheet assets 31/12/2022 25,365 |
Sub-total in balance sheet assets31/12/202119,038 | Sub-total in balance sheet assetsVariation6,327 |
Euro investment funds | Euro investment funds 31/12/2022 (1,115) |
Euro investment funds 31/12/2021(2,598) |
Euro investment funds Variation1,483 |
Negotiable debt instruments (Euro) maturing after 3 months | Negotiable debt instruments (Euro) maturing after 3 months 31/12/2022 - |
Negotiable debt instruments (Euro) maturing after 3 months 31/12/2021(50) |
Negotiable debt instruments (Euro) maturing after 3 months Variation50 |
Negotiable debt instruments (non Euro) maturing after 3 months | Negotiable debt instruments (non Euro) maturing after 3 months 31/12/2022 - |
Negotiable debt instruments (non Euro) maturing after 3 months 31/12/2021- |
Negotiable debt instruments (non Euro) maturing after 3 months Variation- |
Shares received as guarantees | Shares received as guarantees 31/12/2022 - |
Shares received as guarantees 31/12/2021(408) |
Shares received as guarantees Variation408 |
Bonds | Bonds 31/12/2022 (17,236) |
Bonds 31/12/2021(7,500) |
Bonds Variation(9,736) |
Treasury shares | Treasury shares 31/12/2022 - |
Treasury shares 31/12/2021- |
Treasury shares Variation- |
Accrued interest | Accrued interest 31/12/2022 (96) |
Accrued interest 31/12/2021(49) |
Accrued interest Variation(47) |
Marketable securities included in financial assets in the cash flow statement | Marketable securities included in financial assets in the cash flow statement 31/12/2022 (18,447) |
Marketable securities included in financial assets in the cash flow statement31/12/2021(10,605) | Marketable securities included in financial assets in the cash flow statementVariation(7,842) |
Cash advances to subsidiaries (cash pooling agreements) included in “other operating receivables” in the balance sheet | Cash advances to subsidiaries (cash pooling agreements) included in “other operating receivables” in the balance sheet 31/12/2022 - |
Cash advances to subsidiaries (cash pooling agreements) included in “other operating receivables” in the balance sheet 31/12/2021- |
Cash advances to subsidiaries (cash pooling agreements) included in “other operating receivables” in the balance sheet Variation- |
Cash advances from subsidiaries (cash pooling agreements) included in “other operating liabilities” in the balance sheet | Cash advances from subsidiaries (cash pooling agreements) included in “other operating liabilities” in the balance sheet 31/12/2022 (8,384) |
Cash advances from subsidiaries (cash pooling agreements) included in “other operating liabilities” in the balance sheet 31/12/2021(6,872) |
Cash advances from subsidiaries (cash pooling agreements) included in “other operating liabilities” in the balance sheet Variation(1,512) |
Cash and cash equivalents, closing balance in the cash flow statement* | Cash and cash equivalents, closing balance in the cash flow statement* 31/12/2022 (1,466) |
Cash and cash equivalents, closing balance in the cash flow statement*31/12/20211,561 | Cash and cash equivalents, closing balance in the cash flow statement*Variation(3,027) |
Elimination of the effect of currency fluctuations | Elimination of the effect of currency fluctuations 31/12/2022
|
Elimination of the effect of currency fluctuations 31/12/2021
|
Elimination of the effect of currency fluctuations Variation(132) |
Elimination of net financial income on cash and cash equivalents and other items | Elimination of net financial income on cash and cash equivalents and other items 31/12/2022
|
Elimination of net financial income on cash and cash equivalents and other items 31/12/2021
|
Elimination of net financial income on cash and cash equivalents and other items Variation(48) |
NET VARIATION IN CASH AND CASH EQUIVALENTS IN THE CASH FLOW STATEMENT* | NET VARIATION IN CASH AND CASH EQUIVALENTS IN THE CASH FLOW STATEMENT* 31/12/2022
|
NET VARIATION IN CASH AND CASH EQUIVALENTS IN THE CASH FLOW STATEMENT*31/12/2021
|
NET VARIATION IN CASH AND CASH EQUIVALENTS IN THE CASH FLOW STATEMENT*Variation(3,207) |
* See the Cash flow statement
(1) Including €108 million corresponding to all debit balances relating to margin calls on derivatives at 31 December 2022, compared to €36 million at 31 December 2021 (see note 18 (3)).
As of 2018, the cash positions of all subsidiaries in the cash flow statement are classified by reference to criteria of autonomy.
An entity is considered non-autonomous when it is a holding company, generates the majority of its sales with EDF group entities, or does not have the status of employer.
The main subsidiaries classified as non-autonomous are C2, C3, EDF Holding and EDF International, and the main subsidiaries classified as autonomous are Enedis, PEI, Sofilo and GGF.
In the cash flow statement, the cash positions of autonomous subsidiaries are presented as a deduction from Cash and cash equivalents. The cash positions of non-autonomous subsidiaries are included in the components of the changes in working capital.
Foreign currency receivables and payables are translated into Euros at the year-end exchange rates. The resulting translation differences are recorded in the balance sheet under “Unrealised foreign exchange gains” and “Unrealised foreign exchange losses”. Provisions are recorded to cover all unrealised exchange losses on foreign currency borrowings not hedged for exchange risks. Unrealised gains are not recognised in the income statement.
Unrealised gains and losses on currency derivatives classified as hedging instruments are recorded in the balance sheet in the revaluation surplus accounts, and netted with the unrealised foreign exchange gains and losses booked in respect of the hedged items, in compliance with ANC regulation 2015-05 of 2 July 2015 on forward financial instruments and hedging operations. Realised gains and losses on hedging derivatives are recognised in the income statement symmetrically to gains and losses on the hedged item.
Foreign exchange gains and losses on trade receivables and payables are recorded in operating income and expenses.
Unrealised foreign exchange losses at 31 December 2022 amount to €1,906 million, principally reflecting: